Abemaciclib 50mg tablets
NHS hospitals in England used £63,626,864 of indicative cost of Abemaciclib 50mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 9.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Abemaciclib 50mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Abemaciclib 50mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £6,415,618 |
| Portsmouth Hospitals Nhs Trust | £2,500,125 |
| Royal Surrey County Hosp Nhs Found Trust | £2,076,379 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,057,730 |
| The Royal Marsden Nhs Foundation Trust | £2,056,835 |
| Nottingham University Hospitals Trust | £1,606,275 |
| Sheffield Teaching Hospitals Nhs Trust | £1,521,463 |
| Southend Univ Hosp Nhs Foundation Trust | £1,475,843 |
| Univ Hpls Bristol Nhs Foundation Trust | £1,338,352 |
| Western Sussex Hospitals Nhs Found Trust | £1,307,640 |
The primary-care picture
Abemaciclib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Abemaciclib medicine page.